|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
|
|---|---|---|---|---|
| EXPENSES | ||||
| Consulting fees | ||||
| Directors’ compensation | ||||
| Foreign exchange | ||||
| Funds processing fees - private placements | ||||
| Marketing, advertising, and investor relations | ||||
| Office and administrative | ||||
| Professional fees | ||||
| Regulatory and filing | ||||
| Research and development | ||||
| Loss before other items | ||||
| Impairment of intangible assets | ||||
| Other items | ||||
| Interest income | ||||
| Basic and diluted loss per share (in CAD per share) | ||||
| Weighted average number of common shares outstanding basic and diluted (in shares) |
Loading...
